Trade

with

AMAG Pharmaceuticals Inc
(NASDAQ: AMAG)
AdChoices
31.04
-0.37
-1.16%
After Hours :
-
-
-

Open

31.19

Previous Close

31.40

Volume (Avg)

1.43M (452.33k)

Day's Range

30.59-31.68

52Wk Range

16.49-33.57

Market Cap.

691.68M

Dividend Rate ( Yield )

-

Beta

0.08

Shares Outstanding

21.96M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 80.86M

    • Net Income

    • -9.60M

    • Market Cap.

    • 691.68M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -13.99

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.08

    • Forward P/E

    • -

    • Price/Sales

    • 7.74

    • Price/Book Value

    • 3.58

    • Price/Cash flow

    • -103.09

      • EBITDA

      • -8.53M

      • Return on Capital %

      • -3.50

      • Return on Equity %

      • -6.84

      • Return on Assets %

      • -3.50

      • Book Value/Share

      • 8.79

      • Shares Outstanding

      • 21.96M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 26.20

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 110.90

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 87.13

            • 82.75

            • Pre-Tax Margin

            • -13.99

            • 39.38

            • Net Profit Margin

            • -13.99

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 86.80

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -166.90

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -164.70

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.85

              • 0.76

              • Current Ratio

              • 11.40

              • 2.92

              • Quick Ratio

              • 10.68

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 2.33

              • 2.21

              • Book Value/Share

              • 8.79

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -55.25

                • 238.10

                • P/E Ratio 5-Year High

                • -92.15

                • 634.30

                • P/E Ratio 5-Year Low

                • -21.82

                • 124.82

                • Price/Sales Ratio

                • 7.74

                • 8.94

                • Price/Book Value

                • 3.58

                • 8.12

                • Price/Cash Flow Ratio

                • -103.09

                • 47.85

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -6.84

                    (-29.10)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -3.50

                    (-22.30)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -3.60

                    (-29.10)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • 0.65

                  • 1.48

                  • Asset Turnover

                  • 0.25

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -11.62M
                  Operating Margin
                  -14.37
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -103.09
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  77.57%

                  Mutual Fund Ownership

                  32.13%

                  Float

                  71.03%

                  5% / Insider Ownership

                  4.37%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    950,909

                  • 0.00

                  • 4.33

                  • BMO Small Cap Growth Fund

                  •  

                    918,852

                  • -16.46

                  • 4.18

                  • SPDR® S&P Biotech ETF

                  •  

                    669,319

                  • 0.60

                  • 2.93

                  • Vanguard Total Stock Mkt Idx

                  •  

                    369,250

                  • 0.00

                  • 1.68

                  • iShares Russell 2000 (AU)

                  •  

                    304,524

                  • 0.00

                  • 1.33

                  • iShares US Pharmaceuticals

                  •  

                    254,350

                  • 0.00

                  • 1.11

                  • T. Rowe Price Small Cap Stock Fund

                  •  

                    251,500

                  • -50.25

                  • 1.15

                  • iShares Nasdaq Biotechnology

                  •  

                    250,154

                  • 0.00

                  • 1.09

                  • Fidelity® Select Pharmaceuticals Port

                  •  

                    235,500

                  • -7.79

                  • 1.07

                  • Vanguard Extended Market Index Fund

                  •  

                    217,857

                  • 1.11

                  • 0.99

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Adage Capital Partners Gp LLC

                  •  

                    3,796,592

                  • 0.00%

                  • 17.29

                  • Visium Asset Management LLC

                  •  

                    2,070,870

                  • +3.53%

                  • 9.43

                  • BMO Asset Management Inc.

                  •  

                    1,999,631

                  • +17.01%

                  • 9.11

                  • Broadfin Capital, LLC

                  •  

                    1,960,775

                  • +126.13%

                  • 8.93

                  • Palo Alto Investors, LLC

                  •  

                    1,614,536

                  • -50.00%

                  • 7.35

                  • Fidelity Management and Research Company

                  •  

                    1,143,873

                  • -0.33%

                  • 5.21

                  • State Street Corp

                  •  

                    1,119,465

                  • -11.80%

                  • 5.10

                  • BlackRock Fund Advisors

                  •  

                    1,091,823

                  • +8.75%

                  • 4.97

                  • BMO Asset Management Corp.

                  •  

                    919,934

                  • -16.44%

                  • 4.19

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  AMAG Pharmaceuticals Inc is a Delaware corporation was founded in 1981. The Company is a specialty pharmaceutical company that markets Feraheme® Injection for Intravenous, or IV, use to treat iron deficiency anemia, or IDA, and MuGar...mored® Mucoadhesive Oral Wound Rinse for the management of oral mucositis. The Company sells Feraheme to authorized wholesalers and specialty distributors who, in turn, sell Feraheme to healthcare providers who administer Feraheme primarily within hospitals, hematology and oncology centers and nephrology clinics. In addition, it also outsource a number of its product supply chain services to ICS, its third-party logistics provider, including services related to warehousing and inventory management, distribution, chargeback processing, accounts receivable management and custo...moremer service call center management. The Company is subject to extensive additional federal, state and foreign healthcare regulation, which includes but is not limited to, the Federal False Claims Act, the Federal Anti-Kickback Statute, the Foreign Corrupt Practices Act, and their state analogues, and similar laws in countries outside of the U.S.lessless

                  Key People

                  William K. Heiden

                  CEO/Director/President

                  Gino Santini

                  Director/Chairman of the Board

                  Scott A Holmes

                  CFO/Chief Accounting Officer/Senior VP, Divisional/Treasurer

                  Mr. Frank E. Thomas

                  COO/Executive VP

                  James R. Sulat

                  Director

                  • AMAG Pharmaceuticals Inc

                  • 1100 Winter Street

                  • Waltham, MA 02421

                  • USA.Map

                  • Phone: +1 617 498-3300

                  • Fax: +1 617 499-3361

                  • amagpharma.com

                  Incorporated

                  1981

                  Employees

                  148

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: